Literature DB >> 18492633

Planning for end-of-life care: findings from the Canadian Study of Health and Aging.

Douglas D Garrett1, Holly Tuokko, Kelli I Stajduhar, Joan Lindsay, Sharon Buehler.   

Abstract

Steps involved in formalizing end-of-life care preferences and factors related to these steps are unclear in the literature. Using data from the third wave of the Canadian Study of Health and Aging (CSHA-3), we examined the relations between demographic and health predictors, on the one hand, and three outcomes, on the other (whether participants had thought about, discussed , or formalized their end-of-life preferences), and considered, as well, whether relations existed among the three outcomes. Canadian region of residence, female gender, and more years of education predicted having thought about preferences; region of residence, female gender, and lack of cognitive impairment predicted discussion of preferences; and region of residence and not being married predicted whether formal documents were in place. Ontario residents were most likely to have thought about, discussed, and formalized their preferences, whereas Atlantic residents were least likely to. Finally, having thought about preferences was associated with discussion, and having thought about and having discussed preferences were each associated with formalization of preferences. These findings are in keeping with the position that Advance Directives (AD) execution is a multi-stage process. A better understanding of this process may prove useful for the development of interventions to promote planning for end-of-life care.

Entities:  

Mesh:

Year:  2008        PMID: 18492633     DOI: 10.3138/cja.27.1.011

Source DB:  PubMed          Journal:  Can J Aging        ISSN: 0714-9808


  9 in total

1.  Trajectories of preparation for future care among first-degree relatives of Alzheimer's disease patients: an ancillary study of ADAPT.

Authors:  Wingyun Mak; Silvia Sörensen
Journal:  Gerontologist       Date:  2011-11-01

2.  Cancer patients' preferences for control at the end of life.

Authors:  Deborah L Volker; Hung-Lan Wu
Journal:  Qual Health Res       Date:  2011-07-06

3.  A clinical framework for improving the advance care planning process: start with patients' self-identified barriers.

Authors:  Adam D Schickedanz; Dean Schillinger; C Seth Landefeld; Sara J Knight; Brie A Williams; Rebecca L Sudore
Journal:  J Am Geriatr Soc       Date:  2009-01       Impact factor: 5.562

4.  'The calendar is just about up': older adults with multiple chronic conditions reflect on death and dying.

Authors:  Laura Hurd Clarke; Alexandra Korotchenko; Andrea Bundon
Journal:  Ageing Soc       Date:  2012-11-01

5.  Planning for serious illness by the general public: a population-based survey.

Authors:  Donna Goodridge; Elizabeth Quinlan; Rosemary Venne; Paulette Hunter; Doug Surtees
Journal:  ISRN Family Med       Date:  2013-12-30

6.  Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.

Authors:  Samuel Golpanian; Darcy L DiFede; Aisha Khan; Ivonne Hernandez Schulman; Ana Marie Landin; Bryon A Tompkins; Alan W Heldman; Roberto Miki; Bradley J Goldstein; Muzammil Mushtaq; Silvina Levis-Dusseau; John J Byrnes; Maureen Lowery; Makoto Natsumeda; Cindy Delgado; Russell Saltzman; Mayra Vidro-Casiano; Marietsy V Pujol; Moisaniel Da Fonseca; Anthony A Oliva; Geoff Green; Courtney Premer; Audrey Medina; Krystalenia Valasaki; Victoria Florea; Erica Anderson; Jill El-Khorazaty; Adam Mendizabal; Pascal J Goldschmidt-Clermont; Joshua M Hare
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-12       Impact factor: 6.053

7.  Planning for Serious Illness amongst Community-Dwelling Older Adults.

Authors:  Donna Goodridge
Journal:  Nurs Res Pract       Date:  2013-04-04

8.  Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial.

Authors:  Sandra L Carroll; Michael McGillion; Dawn Stacey; Jeff S Healey; Gina Browne; Heather M Arthur; Lehana Thabane
Journal:  Trials       Date:  2013-10-22       Impact factor: 2.279

9.  Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.

Authors:  Samuel Golpanian; Darcy L DiFede; Marietsy V Pujol; Maureen H Lowery; Silvina Levis-Dusseau; Bradley J Goldstein; Ivonne H Schulman; Bangon Longsomboon; Ariel Wolf; Aisha Khan; Alan W Heldman; Pascal J Goldschmidt-Clermont; Joshua M Hare
Journal:  Oncotarget       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.